High affinity rigidified AT2 receptor ligands with indane scaffolds

被引:7
|
作者
Wallinder, Charlotta [1 ]
Skold, Christian [1 ]
Sundholm, Sara [1 ]
Guimond, Marie-Odile [3 ]
Yahiaoui, Samir [1 ]
Lindeberg, Gunnar [1 ]
Gallo-Payet, Nicole [3 ]
Hallberg, Mathias [2 ]
Alterman, Mathias [1 ]
机构
[1] Uppsala Univ, BMC, Dept Med Chem, POB 574, SE-75123 Uppsala, Sweden
[2] Uppsala Univ, BMC, Div Biol Res Drug Dependence, Beijer Lab,Dept Pharmaceut Biosci, POB 591, SE-75124 Uppsala, Sweden
[3] Univ Sherbrooke, Fac Med & Hlth Sci, Serv Endocrinol, Sherbrooke, PQ J1H 5N4, Canada
基金
瑞典研究理事会; 加拿大健康研究院;
关键词
2; ANGIOTENSIN-II; NEURITE OUTGROWTH; AT2; RECEPTOR; BIOLOGICAL EVALUATION; TYPE-2; NG108-15; AGONISTS; ANTAGONISTS; KINASE; AT2-RECEPTOR;
D O I
10.1039/c9md00402e
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Rigidification of the isobutyl side chain of drug-like AT(2) receptor agonists and antagonists that are structurally related to the first reported selective AT(2) receptor agonist 1 (C21) delivered bioactive indane derivatives. Four enantiomer pairs were synthesized and the enantiomers were isolated in an optical purity >99%. The enantiomers 7a, 7b, 8a, 8b, 9a, 9b, 10a and 10b bind to the AT(2) receptor with moderate (K-i = 54-223 nM) to high affinity (K-i = 2.2-7.0 nM). The enantiomer with positive optical rotation (+) exhibited the highest affinity at the receptor. The indane derivatives 7b and 10a are among the most potent AT(2) receptor antagonists reported so far. As illustrated by the enantiomer pairs 7a/b and 10a/b, an alteration at the stereogenic center has a pronounced impact on the activation process of the AT(2) receptor, and can convert agonists to antagonists and vice versa.
引用
收藏
页码:2146 / 2160
页数:15
相关论文
共 50 条
  • [41] Update on the Angiotensin AT2 Receptor
    Claudia A. McCarthy
    Robert E. Widdop
    Kate M. Denton
    Emma S. Jones
    Current Hypertension Reports, 2013, 15 : 25 - 30
  • [42] Selectively Promiscuous Opioid Ligands: Discovery of High Affinity/Low Efficacy Opioid Ligands with Substantial Nociceptin Opioid Peptide Receptor Affinity
    Kumar, Vinod
    Ridzwan, Irna E.
    Grivas, Konstantinos
    Lewis, John W.
    Clark, Mary J.
    Meurice, Claire
    Jimenez-Gomez, Corina
    Pogozheva, Irina
    Mosberg, Henry
    Traynor, John R.
    Husbands, Stephen M.
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (10) : 4049 - 4057
  • [43] A convenient transesterification method for synthesis of AT2 receptor ligands with improved stability in human liver microsomes
    Wannberg, Johan
    Isaksson, Rebecka
    Bremberg, Ulf
    Backlund, Maria
    Savmarker, Jonas
    Hallberg, Mathias
    Larhed, Mats
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (03) : 519 - 522
  • [44] High affinity sugar ligands of C-type lectin receptor langerin
    Ota, Fumi
    Hirayama, Tetsuya
    Kizuka, Yasuhiko
    Yamaguchi, Yoshiki
    Fujinawa, Reiko
    Nagata, Masahiro
    Ismanto, Hendra S.
    Lepenies, Bernd
    Aretz, Jonas
    Rademacher, Christoph
    Seeberger, Peter H.
    Angata, Takashi
    Kitazume, Shinobu
    Yoshida, Keiichi
    Betsuyaku, Tomoko
    Kida, Kozui
    Yamasaki, Sho
    Taniguchi, Naoyuki
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2018, 1862 (07): : 1592 - 1601
  • [45] N,N'-DISUBSTITUTED ACETAMIDINES - HIGH-AFFINITY SIGMA RECEPTOR LIGANDS
    REDDY, NL
    FISCHER, JB
    HOWIE, KJB
    WONG, WJ
    BARMETTLER, P
    RHODES, MR
    KEANA, JFW
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1993, 205 : 71 - MEDI
  • [46] Synthesis and in vivo evaluation of 2 high-affinity 76Br-labeledf σ2-receptor ligands
    Rowland, Douglas J.
    Tu, Zhude
    Xu, Jinbin
    Ponde, Datta
    Mach, Robert H.
    Welch, Michael J.
    JOURNAL OF NUCLEAR MEDICINE, 2006, 47 (06) : 1041 - 1048
  • [47] High-affinity fluorescent ligands for the 5-HT3 receptor
    Simonin, Jonathan
    Vernekar, Sanjeev Kumar V.
    Thompson, Andrew J.
    Hothersall, J. Daniel
    Connolly, Christopher N.
    Lummis, Sarah C. R.
    Lochner, Martin
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (02) : 1151 - 1155
  • [48] AT2 RECEPTOR-INTERACTING PROTEIN ATTENUATES ISCHEMIC BRAIN DAMAGE IN CONCERT WITH AT2 RECEPTOR ACTIVATION
    Iwanami, J.
    Mogi, M.
    Wang, X.
    Tsukuda, K.
    Higaki, A.
    Kukida, M.
    Nakaoka, H.
    Yamauchi, T.
    Bai, H.
    Shan, B.
    Min, L.
    Horiuchi, M.
    JOURNAL OF HYPERTENSION, 2017, 35 : E268 - E268
  • [49] Transcriptional regulation of AT2 receptor and AT2 receptor binding protein (ATBP) genes by PARP-1
    Reinemund, J.
    Steckelings, U. M.
    Katerbaum, M.
    Schacherl, J.
    Schefe, J. H.
    Unger, T.
    Funke-Kaiser, H.
    JOURNAL OF HYPERTENSION, 2008, 26 : S141 - S141
  • [50] Improvement of inflammatory vascular injury by AT1 receptor blocker depends on AT1 receptor blockade and AT2 receptor stimulation:: Evaluation of the role of AT2 receptor using AT2 receptor null mice
    Wu, L
    Iwai, M
    Nakagami, H
    Chen, R
    Akishita, M
    Horiuchi, M
    CIRCULATION, 2000, 102 (18) : 275 - 275